[Immunologic status of alcoholic patients with pulmonary tuberculosis].
Aliev. N A NA; Guseĭnov. Sh G ShG; Khavinson. V Kh VKh; Seryĭ. S V SV
Key Findings
- Alcoholic TB patients showed marked T‑cell immunodeficiency and elevated humoral immunity.
- The T‑cell problem appears linked to a blockage at the pro‑thymocyte stage of development.
- Administering thymalin markedly improved immune parameters in these patients.
Practical Outcomes
- Thymalin shows promise as an immune‑boosting peptide in serious disease contexts, but the study is limited to alcoholic TB patients and provides no dosage or safety data for healthy individuals. Biohackers should view this as preliminary evidence of immunomodulatory potential, not a ready‑to‑use protocol for longevity or performance enhancement.
Summary
In a study of 60 alcohol‑dependent people with lung TB, researchers found weak T‑cell immunity and higher antibody levels, likely because T‑cells get stuck early in development. Giving the peptide thymalin helped restore immune balance, suggesting it can boost T‑cell function in severely ill patients.
Abstract
Monoclonal antibodies were used to study the T and B immunity systems in 60 alcoholic patients suffering from pulmonary tuberculosis. The patients with that combined pathology demonstrated marked immunodeficiency as regards the T system and an increase of humoral immunity. It is assumed that one of the main causes of immunodeficiency lies in the blockade of the differentiation of T cells at the stage of T prothymocytes. The rise of the level of humoral immunity is connected to a decline of T suppressors. Administration of thymalin to patients with associated alcoholism and pulmonary tuberculosis was found to be highly effective.
Study Information
pubmed
1991